The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence

Journal of Molecular Biology

Volumn 266, Issue 2, 1997, Pages 367-380

  Malkowski, Michael G ^a   Lazar, Jerome B ^b   Johnson, Paul H ^c   Edwards, Brian F P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

^c BAYER AG   (Germany)

Author keywords

Chemokines; NAP 2; Platelet proteins; Protein structure; X ray crystallography

Indexed keywords

BASIC PROTEIN; BETA THROMBOGLOBULIN; CHEMOKINE; INTERLEUKIN 8; PROTEIN PRECURSOR; THROMBOCYTE FACTOR 4;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; CONNECTIVE TISSUE; CRYSTAL STRUCTURE; GENETIC CONSERVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0031581814     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0796     Document Type: Article

References (76)

1. Ahuja S. K., Lee J. C., Murphy P. M. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. J. Biol. Chem. 271:1996;225-232.
2. Baggiolini M., Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Letters. 307:1992;97-101.
3. Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1989;1045-1049.
4. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Advan. Immunol. 55:1994;97-179.
5. Baker E. N., Hubbard R. E. Hydrogen bonding in globular proteins. Prog. Biophys. Mol. Biol. 44:1984;97-179.
6. Baldwin E. T., Weber I. T., St. Charles R., Xuan J.-C., Apella E., Yamada M., Matsushima K., Edwards B. F. P., Clore G. M., Gronenborn A. M., Wlodawer A. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc. Natl Acad. Sci. USA. 88:1991;502-506.
7. Bebawy S. T., Gorka J., Hyers T. M., Webster R. O. In vitro effects of platelet factor 4 on normal human neutrophil functions. J. Leukocyte Biol. 39:1986;423-434.
8. Bernstein F. C., Koetzle T. F., Williams G. J. B., Meyer E. F. J., Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The protein data bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
9. Brünger A. T. Crystallographic refinement by simulated annealing: application to a 2.8 Å resolution structure of aspartate aminotransferase. J. Mol. Biol. 203:1988;803-816.
10. Car B. D., Baggiolini M., Walz A. Formation of neutrophil-activating peptide 2 from platelet derived connective tissue-activating peptide III by different tissue proteinases. Biochem. J. 275:1991;581-584.
11. Castor C. W., Walz D. A., Johnson P. H., Hossler P. A., Smith E. M., Bignall M. C., Aaron B. P., Underhill P., Lazar J. M., Hudson D. H., Cole L. A., Perini F., Mountjoy K. Connective tissue activiation XXXIV: effects of proteolytic processing on the biologic activities of CTAP-III. J. Lab. Clin. Med. 116:1990;516-526.
12. Cerretti D. P., Kozlosky C. J., van den Bos T., Nelson N., Gearing D. P., Beckman M. P. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity, and neutrophil-activating peptide-2. Mol. Immunol. 30:1993;359-367.
13. Chambers J. L., Ortega R. B., Campana C. F. Macromolecular data collection strategy. American Crystallographic Association, 50th Annual Meeting. 1992.
14. Ciaglowski R. E., Snow J. W., Walz D. A. Isolation and amino acid sequence of bovine platelet factor 4. Arch. Biochem. Biophys. 250:1986;249-256.
15. Clark-Lewis I., Schumacher C., Baggiolini M., Moser B. Structure-activity relationship of interleukin-8 determined using chemically synthesized analogs. J. Biol. Chem. 266:1991;23128-23134.
16. Clark-Lewis I., Dewald B., Geiser T., Moser B., Baggiolini M. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc. Natl Acad. Sci. USA. 90:1993;3574-3577.
17. Clark-Lewis I., Dewald B., Loetscher M., Moser B., Baggiolini M. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J. Biol. Chem. 269:1994;16075-16081.
18. Clark-Lewis I., Kim K-S., Rajarathnam K., Gong J-H., Dewald B., Moser B., Baggiolini M., Sykes B. D. Structure-activity relationships of chemokines. J. Leukocyte Biol. 57:1995;703-711.
19. Clore G. M., Apella E., Yamada M., Matsushima K., Gronenborn A. M. Three-dimensional structure of interleukin-8 in solution. Biochemistry. 29:1990;1689-1696.
20. Cohen A. B., Stevens M. D., Miller E. J., Atkinson M. A. L., Mullenbach G. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets. Am. J. Physiol. 263:1992;L249-L256.
21. Deuel T. F., Keim P. S., Farmer M., Heinrikson R. L. Amino acid sequence of human platelet factor 4. Proc. Natl Acad. Sci. USA. 74:1977;2256-2258.
22. Deuel T. F., Senior R. M., Chang D., Griffin G. L., Heinrikson R. L., Kaiser E. T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl Acad. Sci. USA. 78:1981;4584-4587.
23. Engh R. A., Huber R. Accurate bond angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A. 47:1991;392-400.
24. Fairbrother W. J., Reily D., Colby T., Horuk R. H assignment and secondary structure determination of human melanoma growth stimulating activity (MGSA) by NMR spectroscopy. FEBS Letters. 330:1994;302-306.
25. Gewirtz A. M., Zhang J., Ratajczak J., Ratajczak M., Park K. S., Li C., Yan Z., Poncz M. Chemokine regulation of human megakaryocytopoiesis. Blood. 86:1995;2559-2567.
26. Haskill S., Peace A., Morris J., Sporn S. A., Anisowicz A., Lee S. W., Smith T., Martin G., Ralph P., Sager R. Indentification of three related human GRO genes encoding cytokine functions. Proc. Natl Acad. Sci. USA. 87:1990;7732-7736.
27. Hébert C. A., Luscinskas F. W., Keily J.-M., Luis E. A., Darbonne W. C., Bennett G. L., Liu C. C., Obin M. S., Gimborne M. A. J., Baker J. B. Endothelial and leukocyte forms of IL-8: conversion by thrombin and interactions with neutrophils. J. Immunol. 145:1990;3033-3040.
28. Hébert C. A., Vitangcol R. V., Baker J. B. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Biol. Chem. 266:1991;18989-18994.
29. Hermodson M., Schmer G., Kurachi K. Isolation, crystallization, and primary amino acid sequence of human platelet factor 4. J. Biol. Chem. 252:1977;6276-6279.
30. Holmes W. E., Lee J., Kuang W., Rice G. C., Wood W. I. Structure and functional expression of a human interleukin-8 receptor. Science. 253:1991;1278-1280.
31. Holt J. C., Harris M. E., Holt A. M., Lange E., Henschen A., Niewarowski S. Characterization of human platelet basic protein, a precursor form of low affinity platelet factor 4 and b-thromboglobulin. Biochemistry. 25:1986;1988-1996.
32. Hoogewerf A. J., Leone J. W., Reardon I. M., Howe W. J., Asa D., Heinrikson R., Ledbetter S. R. CXC chemokines connective tissue activating peptide-III and neutrophil-activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem. 270:1995;3268-3277.
33. Howard A. J., Gilliland G. L., Finzel B. C., Poulos T. L., Ohlendorf D. H., Salemme F. R. The use of an imaging proportional counter in macromolecular crystallography. J. Appl. Crystallog. 20:1987;383-387.
34. Kim K.-S., Clark-Lewis I., Sykes B. D. Solution structure of GRO/melanoma growth stimulating activity determined by H NMR spectroscopy. J. Biol. Chem. 269:1994;32909-32915.
35. Kleywegt G. J., Jones A. T. Where freedom is given, liberties are taken. Structure. 3:1995;535-540.
36. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
37. Lindley I., Aschauer H., Seifert J. M., Lam C., Brunowsky W., Kownatzki E., Thelen M., Peveri P., Dewald B., von Tscharner V., Walz A., Baggiolini M. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc. Natl Acad. Sci. USA. 85:1988;9199-9203.
38. Luster A. D., Unkeless J. C., Ravetch J. V. g-interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature. 315:1985;672-676.
39. Luzatti P. V. Traitement statistique des erreurs dans la determination des structures crystallines. Acta Crystallog. 5:1952;802-810.
40. Malkowski M. G., Wu J. Y., Lazar J. B., Johnson P. H., Edwards B. F. P. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9 Å resolution. J. Biol. Chem. 270:1995;7077-7087.
41. Matsushima K., Oppenheim J. J. Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine. 1:1989;2-13.
42. Mayo K. H., Barker S., Kuranda M. J., Hunt A. J., Myers J. A., Maione T. E. Molten globule monomer and condensed dimer: role of disulfide bonds in platelet factor 4 folding and subunit association. Biochemistry. 31:1992;12255-12265.
43. 1H-nuclear magnetic resonance spectroscopy. Biochem. J. 304:1994;371-376.
44. Moser B., Clark-Lewis I., Zwahlen R., Baggiolini M. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J. Exp. Med. 171:1990;1797-1802.
45. Moser B., Schumacher C., von Tscharner V., Clark-Lewis I., Baggiolini M. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide1/interleukin-8 receptors on human neutrophils. J. Biol. Chem. 266:1991;10666-10671.
46. Moser B., Dewald B., Barella L., Schumacher C., Baggiolini M., Clark-Lewis I. Interleukin-8 antagonists generated by N-terminal modification. J. Biol. Chem. 268:1993;7125-7128.
47. Murphy T. M., Tiffany H. L. Cloning of complimentary DNA encoding a functional human interleukin-8 receptor. Science. 253:1991;1280-1283.
48. Oppenheim J. J., Zacharie C. O. C., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:1991;617-648.
49. Park K. S., Rifat S., Eck H., Adachi K., Surrey S., Poncz M. Biologic and biochemic properties of recombinant platelet factor 4 demonstrate identity with the native protein. Blood. 75:1990;1290-1295.
50. Peveri P., Walz A., Dewald B., Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1988;1547-1559.
51. Poncz M., Surrey S., Larocco P., Weiss M. J., Rappaport E. F., Conway T. M., Schwartz E. Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood. 69:1987;219-223.
52. Rajarathnam K., Sykes B. D., Kay C. M., Dewald B., Geiser T., Baggiolini M., Clark-Lewis I. neutrophil activation by monomeric interleukin-8. Science. 264:1994;90-92.
53. Rao S. N., Jih J. H., Hartsuck J. A. Rotation function space groups. Acta Crystallog. sect. A. A36:1980;878-884.
54. Richardson J. The anatomy and taxonomy of protein structure. Advan. Protein Chem. 34:1981;167-339.
55. Rossman M. G., Blow D. M. The detection of sub-units within the crystallographic asymmetric unit. Acta Crystallog. 15:1962;24-31.
56. Satow Y., Cohen G. H., Padlan E. A., Davies D. R. Phosphocholine binding immunoglobulin FAB McPC603: an X-ray diffraction study at 2.7 Å J. Mol. Biol. 190:1986;593-604.
57. Schnitzel W., Monschein U., Bessmer J. Monomer-dimer equilibria of interleukin-8 and neutrophil activating peptide 2. Evidence for IL-8 binding as a dimer and oligomer to IL-8 receptor B. J. Leuk. Biol. 55:1994;763-770.
58. Schröder J.-M., Sticherling M., Henniecke H. H., Preissner W. C., Christophers E. IL-1a or tumor necrosis factor-a stimulate the release of three NAP-1/IL-8 related neutrophil chemotactic proteins in human dermal fibroblasts. J. Immunol. 144:1990;2223-2232.
59. Sherry B., Cerami A. Small cytokine superfamily. Curr. Opin. Immunol. 3:1991;56-60.
60. St. Charles R., Walz D. A., Edwards B. F. P. The three-dimensional structure of bovine platelet factor 4 at 3.0 Å resolution. J. Biol. Chem. 264:1989;2092-2099.
61. Strieter R. M., Polverini P. J., Kunkel S. L., Arenberg D. A., Burdick M. D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriot D., Chan S.-Y., Roczniak S., Shanafelt A. B. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:1995;27348-27357.
62. Stuckey J. A. The structural refinement of native bovine platelet factor 4 and recombinant human platelet factor 4. Dissertation Abstracts. 53:1992;1034-1034.
63. Tekamp-Olson P., Gallegos C., Bauer D., McClain J., Sherry B., Fabre M., Van Deventer S., Cerami A. Cloning and characterization of cDNAs for murine macrophage inflammatory protein-2 and its human homologs. J. Exp. Med. 172:1990;911-919.
64. Van Damme J., Van Beeumen J., Conings R., Decock B., Billiau A. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of β-thromboglobulin. Eur. J. Biochem. 181:1989;337-344.
65. Van Damme J., Rampart M., Conings R., Decock B., Van Osselaer N., Willems J., Billiau A. The neutrophil-activating proteins interleukin-8 and β-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms. Eur. J. Immunol. 20:1990;2113-2118.
66. Waleh N. S., Sohel I., Lazar J. B., Hudson D. V., Sze P., Underhill P. A., Johnson P. H. Expression of synthetic genes encoding fused proteins under tight control of modified regulatory regions of the colicin operon. Gene. 117:1992;7-14.
67. Walz A. Generation and properties of neutrophil-activating peptide-2. Interleukin 8 (NAP-1) and Related Chemotactic Cytokines. 1992;Karger, Basel.
68. Walz A., Baggiolini M. A novel cleavage product of β-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. Biochem. Biophys. Res. Commun. 159:1989;969-975.
69. Walz A., Baggiolini M. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue activating peptide-III through monocyte proteases. J. Exp. Med. 171:1990;449-454.
70. Walz A., Dewald B., von Tscharner V., Baggiolini M. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue activating peptide III, and platelet factor 4 on human neutrophils. J. Exp. Med. 170:1989;1745-1750.
71. Walz A., Burgener R., Car B., Baggiolini M., Kunkel S. L., Strieter R. M. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174:1991;1355-1362.
72. Wernette-Hammond M. E., Shyamala V., Siani M. A., Gallegos C. A., Feucht P. H., Abbott J., Lapointe G. R., Moghadam M., Khoja H., Zakel J., Tekamp-Olsen P. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket. J. Biol. Chem. 271:1996;8228-8235.
73. Wolpe S. D., Davetelis G., Sherry B., Beutler B., Hesse D., Nguyen H. T., Moldawer L. L., Nathan C. F., Lowry S. F., Cerami A. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167:1988;570-581.
74. 1H NMR spectroscopy and circular dichroism. J. Biol. Chem. 269:1994;20110-20118.
75. Yoshimura T., Robinson E., Apella E., Matsushima K., Showalter S. D., Skeel A., Lenard E. J. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol. Immunol. 26:1989;87-93.
76. Zhang X., Chen L., Bancroft D. P., Lai C. K., Maione T. E. Crystal structure of recombinant human platelet factor 4. Biochemistry. 33:1994;8361-8366.